Top Lung Cancer Advances From 2025
Top Lung Cancer Advances From 2025

Chinmay Jani, MD, Ali Al Sbihi, MD, Gilberto Lopes, MD

Ivonescimab Plus Chemotherapy in EGFR+ NSCLC After TKI Therapy
Ivonescimab Plus Chemotherapy in EGFR+ NSCLC After TKI Therapy

Ali Al Sbihi, MD, Chinmay Jani, MD

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Sawyer Bawek, DO

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC
Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

Sawyer Bawek, DO